SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Lantern Pharma Reports $0.7 Million Q3 Net Income, $7.6 Million in Cash and Securities

Lantern Pharma reported third-quarter 2026 net income of approximately $0.7 million, including a non-cash gain from warrant remeasurement, compared with a $4.2 million net loss a year earlier. The company ended September with approximately $7.6 million in cash, cash equivalents and marketable secur…

LTRN

Related stories